Leading industry veteran joins Suvoda to
advance the company's eCOA product ahead of launch
PHILADELPHIA, July 12, 2022 /PRNewswire/ -- Suvoda LLC, a
global clinical trial technology company that specializes in
complex studies in therapeutic areas such as oncology, central
nervous system (CNS), and rare disease, today announced the hiring
of Jill Platko, PhD as Vice
President of Scientific Services. Suvoda has led the way in IRT
(Interactive Response Technology) development for innovative trial
designs, and the addition of Dr. Platko to its team will further
Suvoda's commitment to supporting pharmaceutical and biotechnology
companies throughout the entire clinical trial journey for complex,
Throughout her career, Dr. Platko has set a standard of
excellence while working in challenging business and research
settings and is adept at identifying opportunities for improvement
through information systems and process optimization. In her role,
Dr. Platko will actively collaborate with leadership to drive
Suvoda's Scientific Consulting practice, partnering with sales and
services to ensure customers are set up for success with Suvoda's
eCOA (electronic Clinical Outcome Assessment) product — a solution
on Suvoda's platform that makes it easier for patients to report
critical outcome data, currently in the early adopter phase. Dr.
Platko will review the clinical protocol with customers and provide
both scientific and clinical guidance on Suvoda's design and
Dr. Platko joins Suvoda after serving as Senior Scientific
Advisor at Signant Health, where she consulted with business
development, project delivery, and product development teams and
with clients with respect to eCOA systems for clinical trials.
"We are delighted to have Jill join our team. She is an
accomplished leader in eCOA design and implementation with a record
of success directing multi-disciplinary teams to design innovative
applications that support science-based projects, including
laboratory information system management and clinical research
systems," said Robert Hummel, Chief
Operating Officer of Suvoda. "Her combination of scientific,
clinical, and information technology expertise will only reinforce
Suvoda's ability to deliver cutting-edge solutions designed to
manage the increasing complexity of global clinical trials."
Prior to Signant Health, Dr. Platko worked as the Associate
Director of Global Health Economics and Outcomes Research at
LabCorp Drug Development (formerly Covance), where she provided
scientific consultation and support for projects collecting eCOA.
She earned her PhD in genetics and development from Cornell University.
"I'm thrilled to have joined Suvoda just as the eCOA product is
ready for early adopters," said Dr. Platko. "Rather than cobbling
products together, Suvoda has built a single platform where eCOA,
IRT, and eConsent all talk to each other and operate seamlessly.
This unique approach underscores Suvoda's commitment to quality,
and to me, that's exciting for the future of clinical trials."
Suvoda is a global clinical trial
technology company that specializes in complex, life-sustaining
studies in therapeutic areas like oncology, central nervous system
(CNS), and rare disease. Founded in 2013 by experts in eClinical
technologies, Suvoda empowers clinical trial professionals to
manage the most urgent moments in the most urgent trials through
advanced software solutions delivered on a single platform.
Headquartered outside Philadelphia, Suvoda also maintains offices in
Portland, OR, Barcelona, Spain, Bucharest, Romania and Tokyo, Japan. The company consistently boasts
a Net Promoter Score (NPS) of close to 70, far exceeding the
technology industry average of 50, and has been selected by trial
sponsors and CROs to support more than 1000 trials across 65
countries. To learn more, visit suvoda.com. Follow Suvoda on
Twitter and LinkedIn.